A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Boston Scientific Corp stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 128,709 shares of BSX stock, worth $11.7 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
128,709
Previous 155,834 17.41%
Holding current value
$11.7 Million
Previous $12 Million 10.12%
% of portfolio
0.19%
Previous 0.2%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $1.98 Million - $2.28 Million
-27,125 Reduced 17.41%
128,709 $10.8 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $3.38 Million - $3.9 Million
50,163 Added 47.47%
155,834 $12 Million
Q1 2024

May 03, 2024

BUY
$57.6 - $68.62 $4.22 Million - $5.02 Million
73,219 Added 225.62%
105,671 $7.24 Million
Q4 2023

Feb 09, 2024

SELL
$48.64 - $57.81 $831,695 - $988,493
-17,099 Reduced 34.51%
32,452 $1.88 Million
Q3 2023

Nov 13, 2023

SELL
$50.19 - $54.68 $54,004 - $58,835
-1,076 Reduced 2.13%
49,551 $2.62 Million
Q2 2023

Aug 03, 2023

BUY
$49.72 - $54.64 $453,098 - $497,934
9,113 Added 21.95%
50,627 $2.74 Million
Q1 2023

May 12, 2023

SELL
$45.09 - $50.03 $211,968 - $235,191
-4,701 Reduced 10.17%
41,514 $2.08 Million
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $941,448 - $1.12 Million
23,798 Added 106.16%
46,215 $2.14 Million
Q3 2022

Nov 07, 2022

SELL
$36.71 - $109.66 $103,779 - $310,008
-2,827 Reduced 11.2%
22,417 $868,000
Q2 2022

Aug 12, 2022

BUY
$35.24 - $47.1 $476,726 - $637,168
13,528 Added 115.47%
25,244 $941,000
Q1 2022

May 11, 2022

BUY
$40.9 - $45.1 $479,184 - $528,391
11,716 New
11,716 $519,000
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $129,483 - $163,934
-3,906 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$34.44 - $42.23 $134,522 - $164,950
3,906 New
3,906 $149,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.